Keiji Yoshida

709 total citations
26 papers, 570 citations indexed

About

Keiji Yoshida is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Keiji Yoshida has authored 26 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in Keiji Yoshida's work include Natural product bioactivities and synthesis (4 papers), Bone health and treatments (3 papers) and Hormonal and reproductive studies (3 papers). Keiji Yoshida is often cited by papers focused on Natural product bioactivities and synthesis (4 papers), Bone health and treatments (3 papers) and Hormonal and reproductive studies (3 papers). Keiji Yoshida collaborates with scholars based in Japan and United States. Keiji Yoshida's co-authors include Shigehisa Taketomi, Kohei Notoya, Ryoichi Tsukuda, Yoshiaki Ito, Kojiro Yamaguchi, Takayuki Maruyama, Kosei Ito, Kigen Kondo, Shuh Narumiya and Mutsumi Matsushita and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Bone and Mineral Research and Bone.

In The Last Decade

Keiji Yoshida

26 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiji Yoshida Japan 10 268 148 143 127 73 26 570
James M. Pash United States 15 401 1.5× 86 0.6× 92 0.6× 115 0.9× 35 0.5× 18 643
Y.F. Ma United States 15 336 1.3× 317 2.1× 114 0.8× 162 1.3× 324 4.4× 30 756
J Bonnet France 12 130 0.5× 70 0.5× 55 0.4× 38 0.3× 78 1.1× 17 529
Clifford R. Stevens United Kingdom 10 285 1.1× 85 0.6× 39 0.3× 36 0.3× 53 0.7× 11 571
Kojiro Yamaguchi Japan 8 226 0.8× 153 1.0× 176 1.2× 90 0.7× 58 0.8× 20 517
Kevin Greenslade United Kingdom 9 261 1.0× 129 0.9× 40 0.3× 58 0.5× 120 1.6× 10 464
Roland Blanqué Belgium 13 308 1.1× 178 1.2× 51 0.4× 36 0.3× 36 0.5× 31 559
Martine Bisson Canada 13 264 1.0× 155 1.0× 24 0.2× 57 0.4× 47 0.6× 15 430
Masaaki Takai Japan 14 269 1.0× 146 1.0× 30 0.2× 75 0.6× 17 0.2× 31 620
Eio Koh Japan 14 257 1.0× 56 0.4× 28 0.2× 69 0.5× 16 0.2× 32 692

Countries citing papers authored by Keiji Yoshida

Since Specialization
Citations

This map shows the geographic impact of Keiji Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Yoshida more than expected).

Fields of papers citing papers by Keiji Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiji Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Yoshida. The network helps show where Keiji Yoshida may publish in the future.

Co-authorship network of co-authors of Keiji Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Yoshida. A scholar is included among the top collaborators of Keiji Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Yoshida. Keiji Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshida, Keiji, Hiroji Oida, Takuya Kobayashi, et al.. (2002). Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proceedings of the National Academy of Sciences. 99(7). 4580–4585. 273 indexed citations
2.
Notoya, Kohei, et al.. (1996). Increase in femoral bone mass by ipriflavone alone and in combination with 1α-hydroxyvitamin D3 in growing rats with skeletal unloading. Calcified Tissue International. 58(2). 88–94. 9 indexed citations
3.
Miyabara, Shinichi, Masahiko Ando, Keiji Yoshida, Nakamichi Saito, & Hajime Sugihara. (1994). Absent aortic and pulmonary valves: Investigation of three fetal cases with cystic hygroma and review of the literature. Heart and Vessels. 9(1). 49–55. 19 indexed citations
4.
Notoya, Kohei, Keiji Yoshida, Ryoichi Tsukuda, & Shigehisa Taketomi. (1994). Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture. Journal of Bone and Mineral Research. 9(3). 395–400. 45 indexed citations
5.
Notoya, Kohei, Keiji Yoshida, Shigehisa Taketomi, Iwao Yamazaki, & Masayoshi Kumegawa. (1993). Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells. Calcified Tissue International. 53(3). 206–209. 27 indexed citations
6.
Kohzuki, Masahiro, et al.. (1992). The kidney protecting effect of trandolapril in normotensive and hypertensive diabetic rats. 44(3). 309–315. 2 indexed citations
7.
Notoya, Kohei, Ryoichi Tsukuda, Keiji Yoshida, & Shigehisa Taketomi. (1992). Stimulatory effect of ipriflavone on formation of bone-like tissue in rat bone marrow stromal cell culture. Calcified Tissue International. 51(S1). S16–S20. 22 indexed citations
8.
Notoya, Kohei, Keiji Yoshida, Shigehisa Taketomi, Iwao Yamazaki, & Masayoshi Kumegawa. (1992). Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells. Calcified Tissue International. 51(S1). S3–S6. 22 indexed citations
9.
Miyabara, Shinichi, Hajime Sugihara, Hakaru Tasaki, et al.. (1989). Significance of cardiovascular malformations in cystic hygroma: A new interpretation of the pathogenesis. American Journal of Medical Genetics. 34(4). 489–501. 45 indexed citations
10.
Shino, Akio, Takao Matsuo, Masao Tsuda, et al.. (1985). Effects of Ipriflavone on Bone and Mineral Metabolism in the Streptozotocin Diabetic Rat. 3(3). 177–187. 25 indexed citations
11.
Shiota, Kunio, et al.. (1985). Acute effect of triiodothyronine on the dynamics of thyrotropin release from superfused anterior pituitary cells. Molecular and Cellular Endocrinology. 41(1). 79–84. 5 indexed citations
12.
Shiota, Kunio, et al.. (1984). In vitro thyrotrophin release with thyrotrophin-releasing hormone and an analogue, DN-1417. European Journal of Endocrinology. 106(1). 71–78. 6 indexed citations
13.
Sudo, Katsuichi, et al.. (1984). Radioimmunoassay for serum levels of an antiandrogen TSAA-291 (Oxendolone) in rats.. Journal of Pharmacobio-Dynamics. 7(6). 378–384. 1 indexed citations
14.
15.
Sudo, K, Keiji Yoshida, & Ryo Nakayama. (1982). Specific interaction of radioactive anti-androgen TSAA-291 with androgen receptor in rat prostates. European Journal of Endocrinology. 100(3). 473–480. 3 indexed citations
16.
17.
Yoshida, Keiji, et al.. (1980). Comparative Study of Nepalese and Japanese Placentas. Asia-Oceania Journal of Obstetrics and Gynaecology. 6(2). 131–138. 2 indexed citations
18.
Sudo, K, et al.. (1979). V. EFFECTS OF THE ANTI-ANDROGEN TSAA-291 ON THE ANDROGEN-RECEPTOR COMPLEX FORMATION FROM [3H]TESTOSTERONE IN RAT VENTRAL PROSTATES. European Journal of Endocrinology. 92(3_Supplb). S67–S81. 5 indexed citations
19.
Mori, Kosuke, Tsuneo Hasegawa, Goro Araki, et al.. (1965). A Clinical Evaluation of Transient Focal Cerebral Ischemia with Some Comments on Its Concept. Japanese Circulation Journal. 29(9). 847–854. 5 indexed citations
20.
Satoh, Daisuke, et al.. (1953). Isolation of Two Kinds of Water-soluble Glycosides from the Leaves of Digitalis purpurea L.. Pharmaceutical Bulletin. 1(3). 305–306. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Pash Breakdown of academic impact, for papers by Y.F. Ma Breakdown of academic impact, for papers by J Bonnet Breakdown of academic impact, for papers by Clifford R. Stevens Breakdown of academic impact, for papers by Kojiro Yamaguchi Breakdown of academic impact, for papers by Kevin Greenslade Breakdown of academic impact, for papers by Roland Blanqué Breakdown of academic impact, for papers by Martine Bisson Breakdown of academic impact, for papers by Masaaki Takai Breakdown of academic impact, for papers by Eio Koh
Rankless by CCL
2026